Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marc Alan Pfeffer, M.D., Ph.D.


This page shows the publications co-authored by Marc Pfeffer and Karola Jering.
Connection Strength

  1. From practice changing to hypothesis generating: a virtuous cycle. Eur Heart J. 2020 02 21; 41(8):955-957.
    View in: PubMed
    Score: 0.860
  2. Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. Reply. N Engl J Med. 2022 02 10; 386(6):603.
    View in: PubMed
    Score: 0.247
  3. Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial. Circulation. 2022 01 04; 145(1):87-89.
    View in: PubMed
    Score: 0.243
  4. Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. N Engl J Med. 2021 11 11; 385(20):1845-1855.
    View in: PubMed
    Score: 0.242
  5. Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics. Eur J Heart Fail. 2021 06; 23(6):1040-1048.
    View in: PubMed
    Score: 0.233
  6. Burden of Heart Failure Signs and Symptoms, Prognosis, and Response to Therapy: The PARAGON-HF Trial. JACC Heart Fail. 2021 05; 9(5):386-397.
    View in: PubMed
    Score: 0.231
  7. Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF. JACC Heart Fail. 2021 01; 9(1):13-24.
    View in: PubMed
    Score: 0.226
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.